{"filing":{"accession_number":"0001104659-26-078337","cik":"0001649989","ticker":"OTLK","company_name":"Outlook Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-26","report_date":null,"primary_document":"tm2619105d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926078337/tm2619105d1_8k.htm"},"events":[{"id":14375,"run_id":12795,"accession_number":"0001104659-26-078337","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"The filing discloses a delisting notice under Item 3.01. Although the Company ultimately regained compliance with Nasdaq's minimum bid price rule (Listing Rule 5550(a)(2)) and the delisting matter is now closed as of June 26, 2026, the disclosure documents the Company's prior failure to maintain the $1.00 minimum bid price for 30 consecutive business days (triggering the February 18, 2026 delisting notice) and its subsequent remediation. This is a material event affecting the registrant's listing status and investor confidence, even though the immediate delisting risk has been resolved.","company_name":"Outlook Therapeutics, Inc.","ticker":"OTLK","filing_date":"2026-06-26","form":"8-K","submitted_at":null,"items":[{"id":11774,"accession_number":"0001104659-26-078337","item_number":"3.01","item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a delisting notice under Item 3.01. Although the Company ultimately regained compliance with Nasdaq's minimum bid price rule (Listing Rule 5550(a)(2)) and the delisting matter is now closed as of June 26, 2026, the disclosure documents the Company's prior failure to maintain the $1.00 minimum bid price for 30 consecutive business days (triggering the February 18, 2026 delisting notice) and its subsequent remediation. This is a material event affecting the registrant's listing status and investor confidence, even though the immediate delisting risk has been resolved.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T21:31:39.800770+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11774,"accession_number":"0001104659-26-078337","item_number":"3.01","item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a delisting notice under Item 3.01. Although the Company ultimately regained compliance with Nasdaq's minimum bid price rule (Listing Rule 5550(a)(2)) and the delisting matter is now closed as of June 26, 2026, the disclosure documents the Company's prior failure to maintain the $1.00 minimum bid price for 30 consecutive business days (triggering the February 18, 2026 delisting notice) and its subsequent remediation. This is a material event affecting the registrant's listing status and investor confidence, even though the immediate delisting risk has been resolved.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T21:31:39.800770+00:00","company_name":"Outlook Therapeutics, Inc.","ticker":"OTLK","filing_date":"2026-06-26"}]}